Ashland Bellefonte Cancer Center is categorized under Medical Labs in Ashland, KY and active since 1985.
Ashland Bellefonte Cancer Center was established in 1985, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Manish Jain, Office Manager at the company’s single location by writing to 122 Saint Christopher Drive, Ashland, Kentucky KY 41101 or by phoning (606) 836-0202. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ashland Bellefonte Cancer Center |
Contact Person: | Manish Jain, Office Manager |
Address: | 122 Saint Christopher Drive, Ashland, Kentucky 41101 |
Phone Number: | (606) 836-0202 |
Annual Revenue (USD): | $2.500.000 to $4.999.999 |
Founded: | 1985 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Labs |
SIC Code: | 8071 |
NAICS Code: | 6211110 |
Share This Business: |
Ashland Bellefonte Cancer Center was started in 1985 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Manish Jain, Office Manager for inquiries that concern Ashland Bellefonte Cancer Center by calling the company number (606) 836-0202, as your correspondence is most welcome. Additionally, the physical location of the single location of Ashland Bellefonte Cancer Center can be found at the coordinates 38.51086,-82.69077 as well as the street address 122 Saint Christopher Drive in Ashland, Kentucky 41101.
For its online presence, you may visit Ashland Bellefonte Cancer Center’s website at and engage with its social media outlets through on Twitter and on Facebook.